Добро пожаловать
Нажатие «Авторизоваться» означает, что вы соглашаетесь с Условия использования и политика конфиденциальности Cointime.
Зарегистрировать аккаунт
Аккаунт уже существует?
Нажатие «page.Sign up» означает, что вы соглашаетесь с <a class="underline" href="#term-of-service">Условия использования</a> и a class="underline" href="#privacy-policy">политика конфиденциальности</a> Cointime.
Войдите, используя email
Зарегистрируйтесь с помощью email
твой почтовый ящик
Проверь свои входящие
Нажмите на ссылку в , чтобы войти.
Нажмите на ссылку в , чтобы зарегистрироваться.
Norlase
company
About
Norlase develops next-generation laser solutions for the treatment of retinal and glaucoma disease.
- Ballerup,Hovedstaden,Denmark
- 11 - 50
Details
- Last Funding Type
- Series A
- Last Funding Money Raised
- $4.60M
- Industries
- Consumer Electronics,Laser,Lighting,Medical Device
- Founded date
- Jan 1, 2014
- Number Of Employee
- 11 - 50
- Operating Status
- Active
Norlase is an emerging global ophthalmic medical device company developing next-generation laser solutions for the treatment of retina and glaucoma disease. Norlase is comprised of worldwide industry leaders and experts in ophthalmology, laser technology, medical device development and customer care.
Funding Rounds
Number of Funding Rounds
Total Funding Amount
8
$12.90M £7.15M €1.42M
Norlase has raised a total of
$12.90M £7.15M €1.42M
in funding over 2 rounds. Their latest funding was raised on
Oct 26, 2021 from a Series B round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Oct 26, 2021 | Series B | £7.15M | 1 |
West Hill Capital
|
— | Detail |
| Jan 10, 2021 | Secondary Market | — | 1 | — | — | Detail |
| Sep 1, 2020 | Series Unknown | $4.10M | 1 | — | — | Detail |
| Apr 10, 2019 | Series A | $4.60M | — | — | — | Detail |
| Nov 1, 2018 | Grant | $2.80M | — | — | — | Detail |
Investors
Number of Lead Investors
Number of Investors
1
3
Norlase is funded by 3 investors.
West Hill Capital
and Nordic Secondary Fund
are the most recent investors.
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
|
West Hill Capital
|
Yes | Series B |
Nordic Secondary Fund
|
— | Secondary Market |
EASME - EU Executive Agency for SMEs
|
— | Grant |
Employee Profiles
Number of Employee Profiles
8
Norlase has 8 current employee profiles, including
Executive Jes Broeng
Executive
Executive
Employee
Executive
Executive
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
